Background. The NOVA score is a recently developed diagnostic tool used to identify patients with increased risk of infective endocarditis (IE) among patients with Enterococcus faecalis bacteremia. We aimed to validate the NOVA score and to identify risk factors for IE.
Invasive infections caused by Enterococcus faecalis continue to cause problems worldwide, with rising incidence, healthcarerelated infections, and high mortality rates [1] [2] [3] . Enterococcus faecalis is a frequent cause of bloodstream infections [4] , most often originating in the urinary tract or gastrointestinal tract [3] [4] [5] [6] . The proportion of infective endocarditis (IE) varies from 5.7% when examining bacteremia patients with different kinds of enterococcal species [7] to 13.3% in patients with monomicrobial E. faecalis bacteremia [3] . The risk of developing endocarditis has not been adequately investigated. Only 2 small studies have evaluated independent risk factors for IE in E. faecalis bacteremia patients [8, 9] . In 2002, Fernández-Guerrero et al [9] found that ≥3 positive blood cultures (BCs) and underlying valvulopathy were independently associated with the development of IE in 17 patients. In 2004, Anderson et al [8] found that prosthetic heart valve was independently associated with IE in 41 patients. The diagnosis of E. faecalis IE is challenging, typically with diagnostic delays of several weeks [10] .
Echocardiography is central in diagnosing IE, but transesophageal echocardiography (TEE) can be especially difficult to complete in all patients with E. faecalis bacteremia [11] . Therefore, Bouza et al [12] developed a clinical score (the NOVA score) to help determine in which patients with enterococcal bacteremia a TEE is unnecessary. However, the NOVA score was developed in a limited 1-center case-control study and has not yet been tested in other populations. Therefore, before considering implementation of the NOVA score, external validation is crucial. Since E. faecalis is by far the dominant cause of enterococcal endocarditis [13] , it is highly appropriate to validate the score in E. faecalis bacteremia patients. Therefore, we investigated independent risk factors for developing IE and evaluated the NOVA score in a large cohort of consecutive E. faecalis bacteremia patients examined by echocardiography.
METHODS

Study Population
We systematically collected data from patient files on consecutive patients admitted with E. faecalis bacteremia from 1 January 2010 to 31 December 2013. Our catchment area covers 10 hospitals in the Capital Region of Denmark, corresponding to 1.7 million individuals. Data were collected on demographics, previous endocarditis, previous valve disease, prosthetic heart valve, and cardiac devices. The suspected port of entry for the bacteremia and the mode of acquisition of infection were also registered. Microbiological data were obtained from databases at the Departments of Clinical Microbiology. Additionally, results of transthoracic echocardiography (TTE) and TEE were retrieved. From a total of 661 patients with E. faecalis bacteremia, we found 647 patients eligible for the study (Figure 1 ). Approval was obtained from the Danish Health and Medicines Authorities (3-3013-764/1) and Danish Data Protection Agency (GEH-2014-036).
Definitions
The mode of acquiring E. faecalis bacteremia was categorized as community, in-hospital, or healthcare associated. Communityacquired bacteremia was defined as emerging in the patient's own environment without any relationship to the healthcare system. Healthcare-associated bacteremia was defined as arising in close contact to the healthcare system by one of the following: nursing home residence; recent admission (≥48 hours) within 3 months; invasive surgical procedure within 3 months; and outpatient treatment in terms of intravenous (IV) therapy, hemodialysis, and wound care within 30 days. In-hospital acquisition was defined as bacteremia obtained during a hospital stay with onset of symptoms more than 48 hours after admission [14] .
A BC consists of 2 bottles, 1 aerobic and 1 anaerobic, obtained under aseptic circumstances. When at least 1 of these bottles is positive for growth of E. faecalis, it is defined as a positive BC. Hence, having 3 out of 3 positive BCs requires growth in at least 1 bottle in each of the separate 3 BCs.
Adapted NOVA Score
The NOVA score was created to assess the risk of IE in patients with enterococcal bacteremia [12] . Number (N) of positive BCs is the weightiest factor, with 5 points in case of 3 of 3 positive BCs (or >50% positive if more than 3 BCs). The other factors are bacteremia of unknown origin (O), yielding 4 points; previous valve (V) disease, yielding 2 points; and auscultation (A) of a heart murmur, yielding 1 point. The authors suggested a cutoff below 4 for ruling out IE without doing TEE. Hence, all patients with a NOVA score of 4 or more should be examined with TEE. To apply the NOVA score in our cohort, we had to adapt the score since around half of our patients did not have 3 separate BCs performed. Instead, we defined 2 out of 2 positive BCs (or >50% positive if more than 2 BCs) to result in 5 points in the adapted NOVA score.
Outcome and Follow-up
By using the Danish central patient registry and the central registration of death, we completed a follow-up on all-cause mortality and relapse of bacteremia using each patient's civil registration number. All patients were followed for at least 1 year with a follow-up date of 1 January 2015.
One-year mortality was defined as death within 1 year from positive BCs with E. faecalis.
Statistics
Continuous data were expressed as mean ± standard deviation. Categorical data were given as frequencies and percentage (%). The statistical comparison of continuous data between groups was performed with a 2-sample t test, and the dichotomous variables were evaluated using χ 2 test and Fischer exact test when appropriate. We used Cox regression with backward elimination to evaluate independent risk factors for endocarditis. For all analyses, a 2-sided P value of <.05 was considered significant. All statistical calculations were performed using IBM SPSS, Inc., version 22.0 (Chicago, Illinois).
RESULTS
Clinical Characteristics of 647 Patients With E. faecalis Bacteremia
During the 4-year period, 647 patients were diagnosed with E. faecalis bacteremia. Seventy-eight (12%) of these patients were diagnosed with IE according to the modified Duke criteria [15] . Patients with IE were more often men and more frequently had a pacemaker, prosthetic valve, or other known valvular heart disease compared with non-IE patients (see Table 1 ). Approximately half of the patients had healthcare-associated acquisition of the infection, while community acquisition was significantly more frequent in patients with IE (35.9% vs 16.5%, P < .001; Table 1 ). The urinary system was the most common port of entry for E. faecalis bacteremia. However, an unknown primary focus of the infection was significantly more frequent in IE patients compared with non-IE patients (43.6% vs 23.9%, P < .001; see Table 1 ).
Endocarditis Risk Factors in 647 Patients With E. faecalis Bacteremia
In the univariable Cox regression, male sex, community acquisition, other known valvular disease, pacemaker, previous IE, prosthetic heart valve, unknown origin, and monobacterial Of 661 patients with Enterococcus faecalis (EF) bacteremia, 647 were included, 8 were excluded due to age <18 years, and 6 were excluded due to missing data. Patients were divided into infective endocarditis (IE; 78) and no IE (569) based on diagnosis. Patients were also divided based on whether they had an echocardiography performed (yes/no).
bacteremia were significantly associated with IE ( Figure 2 Figure 2 ).
Clinical Characteristics of 240 Patients Examined by Echocardiography
From the total cohort, 240 patients (37%) had an echocardiography performed, of which 235 (36%) had a TTE and 116 (18%) had a TEE (see Table 1 ). When including only patients who had an echocardiography performed, there was no significant difference between the group with IE and the group without IE with respect to other known valvular heart disease and cardiac devices ( Table 2 ). The number of patients with prosthetic valve was still significantly higher in the IE group compared with the non-IE group (38.5% vs 9.9%, P < .001; see Table 2 ). Both in-hospital (15.4% vs 12.5%, P = .540) and 1-year mortality (34.6% vs 40.6%, P = .372) were comparable in the 2 groups (see Table 2 ).
Adapted NOVA Score
We applied the adapted NOVA score in the 240 patients who underwent echocardiographic examination (Table 3) . A low score (<4) was found in 40 of 240 (17%) patients examined by echocardiography, implying a low likelihood of IE. However, 2 of these patients were diagnosed with IE, resulting in a negative predictive value of 95% ( positive predictive value was 38%). The remaining 76 of the 78 patients with endocarditis had an adapted NOVA score of ≥4, yielding a sensitivity of 97% and a specificity of 23%. One of the 2 patients with IE and adapted NOVA score <4 only had 1 BC performed (both aerobic and anaerobic bottles were positive). In this patient with urosepsis, the infectious parameters did not decrease despite antibiotic treatment, and this prompted the search for IE. The second patient had E. faecalis in 1 of 3 BCs. However, this patient was a former IV drug abuser with a history of IE and had received antibiotic treatment before BCs were done. This combination raised the suspicion of IE.
DISCUSSION
In this retrospective cohort study of risk factors for E. faecalis IE, the main finding was that monomicrobial E. faecalis bacteremia, community acquisition, prosthetic heart valve, and male sex are independently associated with IE. Additionally, both negative predictive value and sensitivity of the adapted NOVA score were high. Our cohort of E. faecalis bacteremia patients had similar characteristics in terms of demographics, predisposing conditions for IE, port of entry, and mode of acquisition, as previously reported [3, 12, 13, 16] . A small case-control study of enterococcal bacteremia by Anderson et al [8] found E. faecalis and prosthetic heart valve to be independently associated with IE. In an earlier study by Fernández et al [9] , univariable analysis showed that age, prosthetic heart valve, known valve disease, 3 or more positive BCs, community acquisition, and monomicrobial bacteremia were associated with the risk of IE. We had sufficient power to show that even in the multivariable analysis, male sex, community-acquired monomicrobial E. faecalis bacteremia, and prosthetic valve remained independently associated with the risk of IE. In our cohort, unknown origin of infection became insignificant when we included community acquisition in the multivariable analysis.
We found an IE prevalence of 12% and high mortality rates of 15% (in hospital) and 35% (1 year), which is well in accordance with earlier studies [3, 5, 7] .
Rates for the use of echocardiography in enterococcal bacteremia have only been reported once, with a rate of 25% for TTE and 12% for TEE [12, 17] . In comparison, echocardiography was used considerably more in our study, with rates of 36% for TTE and 18% for TEE. In the study by Bouza et al [12] that was used to create the NOVA score, 65 cases of IE were found among 1515 patients with mixed enterococcal bacteremia, yielding a low IE rate of 4.3%. As expected, they found low sensitivity of TTE (32%) in diagnosing IE. Also, since a mere 12% were examined with TEE, overlooked cases of IE are a likely explanation for the low IE percentage. Another explanation is mixing E. faecium and E. faecalis instead of evaluating them separately. It is well known that E. faecalis is much more closely associated with the development of IE. A recent study has suggested that E. faecium and E. faecalis should be regarded as different entities with unique characteristics and therefore evaluated separately [18] .
To our knowledge, this is the first study to validate the NOVA score in an external cohort of patients with E. faecalis bacteremia. We found a high sensitivity and negative predictive value, whereas the specificity and positive predictive value were rather low. This is well in accordance with the fact that the NOVA score cutoff (≥4) was chosen in an attempt to capture all cases of IE (sensitivity and negative predictive value of 100%). To achieve that, it is acceptable that the specificity and positive predictive value are lower.
By focusing on E. faecalis in our study design, we found a higher prevalence of IE than the original NOVA score study. Thereby, the predictive values are affected, increasing positive predictive value and decreasing negative predictive value.
Our findings support the use of the NOVA score to help the clinician identify patients with a relatively low risk of IE for which TTE might be sufficient if TEE is difficult to obtain. However, it is important to state that adhering to the NOVA score would prompt many more TEEs than the current clinical practice. In the single-center study by Bouza et al [12] , they anticipated that 70% of the patients would have a high NOVA score and require TEE. Compared with an actually completed rate of 12% TEE, they would have to increase the numbers of TEE 6-fold to follow the NOVA score. Similarly, in our study, we would have to increase the use of TEE in E. faecalis bacteremia 4-fold. We strongly encourage this increase since TEE is an easy and safe examination in the hands of an experienced echocardiographer [19] . Additionally, it is important to keep in mind that endocarditis is a very serious disease and so missing cases can have devastating consequences. If future consecutive screening studies find an even higher percentage of IE, we suggest that all patients with E. faecalis bacteremia be considered for TEE. There are still some questions regarding the usability of the NOVA score in clinical practice. First, if the suggested cutoff for performing TEE remains 4 points, then both auscultation of murmur (1 point) and valvular disease (2 points) becomes redundant since they cannot affect the TEE decision (yes/no). Second, assessing the origin of infection can require a diagnostic workup that takes several days, making it difficult to decide on unknown origin immediately. Instead, it is worth considering use of community acquisition in a clinical risk score since it has been shown to be associated with IE and can be assessed immediately. Third, it is important to remember that scoring systems are thought to assist clinical judgment and not to replace it. This is illustrated by the 2 patients in our study with clinical suspicion of IE despite a low adapted NOVA score.
Whereas the retrospective design of our study is a limitation, the use of a multicenter population-based design is an advantage that reduces possible referral biases seen in tertiary single-center studies. Importantly, not all patients underwent echocardiography; therefore, we risk missing cases of IE in patients not examined with echocardiography. As a consequence, we only applied the adapted NOVA score in the patients examined by echocardiography. Another limitation is that our setup did not include systematic use of 3 separate BCs. By adapting the NOVA score, we made it easier to obtain the 5 points for BCs; therefore, we might have overestimated the sensitivity. On the other hand, the 1 IE patient with a low adapted NOVA score and 1 of 1 positive BCs could have scored higher if 3 BCs had been taken, thereby increasing the sensitivity and negative predictive value. This emphasizes how important it is to perform multiple BCs in patients with E. faecalis bacteremia to help guide clinical decisions.
Monomicrobial E. faecalis bacteremia, community acquisition, prosthetic heart valve, and male sex are independently associated with increased risk of IE. Based on our retrospective cohort of patients with E. faecalis bacteremia, application of the adapted NOVA score can help guide clinical decisions, providing a sensitivity of 97% and a negative predictive value of 95% in the diagnosis of IE.
